This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Samuelson TW, Chang DF, Marquis R, Flowers B, Lim KS, Ahmed IIK, et al. A Schlemm canal microstent for intraocular pressure reduction in primary open-angle glaucoma and cataract: the HORIZON Study. Ophthalmology. 2019;126:29–37.
Ahmed IIK, Rhee DJ, Jones J, Singh IP, Radcliffe N, Gazzard G, et al. Three-year findings of the HORIZON trial: a Schlemm canal microstent for pressure reduction in primary open-angle glaucoma and cataract. Ophthalmology. 2021;128:857–65.
Ahmed IIK, De Francesco T, Rhee D, McCabe C, Flowers B, Gazzard G, et al. Long-term outcomes from the HORIZON randomized trial for a Schlemm’s canal microstent in combination cataract and glaucoma surgery. Ophthalmology. 2022;129:742–51.
Author information
Authors and Affiliations
Contributions
AK led the project and was responsible for conception and design, the headline message, conclusion, infographic legend and drafts/revisions to the infographic/legend. MKL, MZM, FM, JY, and AA contributed ideas and/or data collection and interpretation and/or design elements. CH and RGM oversaw the project and CH recommended drafts/revisions to the infographic and legend.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Korb, A., Low, M.K., Munawar, M.Z. et al. Infographic for HORIZON trial: 5-year findings. Eye (2024). https://doi.org/10.1038/s41433-024-03077-2
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41433-024-03077-2